Fas ligand enhances malignant behavior of tumor cells through interaction with met, hepatocyte growth factor receptor, in lipid rafts

Journal of Biological Chemistry

Volumn 287, Issue 24, 2012, Pages 20664-20673

  Lin, Huan Ching ^a   Lai, Po Yin ^a   Lin, Yu Ping ^a   Huang, Jyun Yuan ^a   Yang, Bei Chang ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL LEVELS; CANCER CELLS; CELL MOTILITY; DOWN-REGULATION; ECTOPIC EXPRESSIONS; EXTRACELLULAR REGION; FAS LIGAND; HEPATOCYTE GROWTH FACTOR RECEPTOR; HUMAN TUMOR CELLS; INTRACELLULAR DOMAIN; LIPID RAFT; LUNG METASTASIS; METASTATIC POTENTIAL; SIGNAL PATHWAYS; SIGNALING MECHANISMS; SIGNALING PATHWAYS; SYNTHETIC PEPTIDE; TRANSFECTANTS; TUMOR CELLS; TUMOR METASTASIS;

CYTOLOGY; GENE EXPRESSION; LIGANDS; PATHOLOGY; PHOSPHORYLATION; TUMORS;

CELLS;

FAS LIGAND; SCATTER FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BINDING SITE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIPID RAFT; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; TUMOR CELL;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MEMBRANE MICRODOMAINS; MICE; NEOPLASM METASTASIS; NIH 3T3 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-MET; SEQUENCE DELETION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

MUS;

EID: 84862019031     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.326058     Document Type: Article

References (31)

1. Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C. A., and Hunter, K. (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131-136
2. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (Pubitemid 24106378)
3. Alderson, M. R., Tough, T. W., Davis-Smith, T., Braddy, S., Falk, B., Schooley, K. A., Goodwin, R. G., Smith, C. A., Ramsdell, F., and Lynch, D. H. (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181, 71-77
4. Cui, H., Sherr, D. H., el-Khatib, M., Matsui, K., Panka, D. J., Marshak-Rothstein, A., and Ju, S. T. (1996) Regulation of T-cell death genes. Selective inhibition of FasL- but not Fas-mediated function. Cell. Immunol. 167, 276-284
5. Nagata, S., and Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456
6. Suzuki, I., and Fink, P. J. (1998) Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187, 123-128 (Pubitemid 28044827)
7. + T cells. Proc. Natl. Acad. Sci. U.S.A. 97, 1707-1712
8. Bodmer, J. L., Schneider, P., and Tschopp, J. (2002) The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27, 19-26 (Pubitemid 34131621)
9. Orlinick, J. R., Elkon, K. B., and Chao, M. V. (1997) Separate domains of the human Fas ligand dictate self-association and receptor binding. J. Biol. Chem. 272, 32221-32229 (Pubitemid 28011899)
10. Watts, A. D., Hunt, N. H., Wanigasekara, Y., Bloomfield, G., Wallach, D., Roufogalis, B. D., and Chaudhri, G. (1999) A casein kinase I motif present in the cytoplasmic domain of members of the tumor necrosis factor ligand family is implicated in "reverse signaling." EMBO J. 18, 2119-2126 (Pubitemid 29179169)
11. Hane, M., Lowin, B., Peitsch, M., Becker, K., and Tschopp, J. (1995) Interaction of peptides derived from the Fas ligand with the Fyn-SH3 domain. FEBS Lett. 373, 265-268
12. Sun, M., Ames, K. T., Suzuki, I., and Fink, P. J. (2006) The cytoplasmic domain of Fas ligand costimulates TCR signals. J. Immunol. 177, 1481-1491 (Pubitemid 44092481)
13. Kirkin, V., Cahuzac, N., Guardiola-Serrano, F., Huault, S., Lückerath, K., Friedmann, E., Novac, N., Wels, W. S., Martoglio, B., Hueber, A. O., and Zörnig, M. (2007) The Fas ligand intracellular domain is released by ADAM10 and SPPL2a cleavage in T-cells. Cell Death Differ 14, 1678-1687 (Pubitemid 47278853)
14. Knox, P. G., Milner, A. E., Green, N. K., Eliopoulos, A. G., and Young, L. S. (2003) Inhibition of metalloproteinase cleavage enhances the cytotoxicity of Fas ligand. J. Immunol. 170, 677-685 (Pubitemid 36070516)
15. P'Reilly, L. A., Tai, L., Lee, L., Kruse, E. A., Grabow, S., Fairlie, W. D., Haynes, N. M., Tarlinton, D. M., Zhang, J. G., Belz, G. T., Smyth, M. J., Bouillet, P., Robb, L., and Strasser, A. (2009) Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature 461, 659-663
16. Chen, Y. L., Chen, S. H., Wang, J. Y., and Yang, B. C. (2003) Fas ligand on tumor cells mediates inactivation of neutrophils. J. Immunol. 171, 1183-1191
17. Chervonsky, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A., Jr., and Matis, L. A. (1997) The role of Fas in autoimmune diabetes. Cell 89, 17-24 (Pubitemid 27180581)
18. Seino, K., Kayagaki, N., Tsukada, N., Fukao, K., Yagita, H., and Okumura, K. (1997) Transplantation of CD95 ligand-expressing grafts. Influence of transplantation site and difficulty in protecting allo- and xenografts. Transplantation 64, 1050-1054 (Pubitemid 27446772)
19. Wang, X., DeFrances, M. C., Dai, Y., Pediaditakis, P., Johnson, C., Bell, A., Michalopoulos, G. K., and Zarnegar, R. (2002) A mechanism of cell survival. Sequestration of Fas by the HGF receptor Met. Mol. Cell 9, 411-421 (Pubitemid 34195565)
20. Lai, A. Z., Abella, J. V., and Park, M. (2009) Cross-talk in Met receptor oncogenesis. Trends Cell Biol. 19, 542-551
21. Ueoka, Y., Kato, K., Kuriaki, Y., Horiuchi, S., Terao, Y., Nishida, J., Ueno, H., and Wake, N. (2000) Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway. Br. J. Cancer 82, 891-899 (Pubitemid 30085243)
22. Cramer, A., Kleiner, S., Westermann, M., Meissner, A., Lange, A., and Friedrich, K. (2005) Activation of the c-Met receptor complex in fibroblasts drives invasive cell behavior by signaling through transcription factor STAT3. J. Cell. Biochem. 95, 805-816 (Pubitemid 41420167)
23. Guo, A., Villén, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., Wang, Y., MacNeill, J., Mitchell, J., Gygi, S. P., Rush, J., Polakiewicz, R. D., and Comb, M. J. (2008) Signaling networks assembled by oncogenic EGFR and c-Met. Proc. Natl. Acad. Sci. U.S.A. 105, 692-697 (Pubitemid 351171770)
24. Wang, R., Kobayashi, R., and Bishop, J. M. (1996) Cellular adherence elicits ligand-independent activation of the Met cell-surface receptor. Proc. Natl. Acad. Sci. U.S.A. 93, 8425-8430 (Pubitemid 26269574)
25. Trusolino, L., Bertotti, A., and Comoglio, P. M. (2001) A signaling adapter function for α6β4 integrin in the control of HGF-dependent invasive growth. Cell 107, 643-654 (Pubitemid 34014865)
26. Popsueva, A., Poteryaev, D., Arighi, E., Meng, X., Angers-Loustau, A., Kaplan, D., Saarma, M., and Sariola, H. (2003) GDNF promotes tubulogenesis of GFRα1-expressing MDCK cells by Src-mediated phosphorylation of Met receptor tyrosine kinase. J. Cell Biol. 161, 119-129 (Pubitemid 36459085)
27. Xiao, S., Deshmukh, U. S., Jodo, S., Koike, T., Sharma, R., Furusaki, A., Sung, S. S., and Ju, S. T. (2004) Novel negative regulator of expression in Fas ligand (CD178) cytoplasmic tail. Evidence for translational regulation and against Fas ligand retention in secretory lysosomes. J. Immunol. 173, 5095-5102 (Pubitemid 39387792)
28. Barnhart, B. C., Legembre, P., Pietras, E., Bubici, C., Franzoso, G., and Peter, M. E. (2004) CD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells. EMBO J. 23, 3175-3185 (Pubitemid 39093611)
29. Härtel, S., Diehl, H. A., and Ojeda, F. (1998) Methyl-beta- cyclodextrins and liposomes as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fluorescence assay and membrane fluidity-sensitive dyes. Anal. Biochem. 258, 277-284 (Pubitemid 28205056)
30. Bradley, M. O., Kraynak, A. R., Storer, R. D., and Gibbs, J. B. (1986) Experimental metastasis in nude mice of NIH 3T3 cells containing various ras genes. Proc. Natl. Acad. Sci. U.S.A. 83, 5277-5281 (Pubitemid 16051358)
31. Jodo, S., Pidiyar, V. J., Xiao, S., Furusaki, A., Sharma, R., Koike, T., and Ju, S. T. (2005) Fas ligand (CD178) cytoplasmic tail is a positive regulator of Fas ligand-mediated cytotoxicity. J. Immunol. 174, 4470-4474